Poster Session 3
Jocelyn Wascher, MD (she/her/hers)
Fellow
University of Chicago Medicine
Chicago, Illinois, United States
Neha Reddy, MD, MPH (she/her/hers)
University of Chicago Medicine
Chicago, Illinois, United States
Camille Johnson
University of Chicago Medicine
Chicago, Illinois, United States
Eryn Wanyonyi
University of Chicago Medicine
Chicago, Illinois, United States
Taytum Kahl
University of Chicago
Chicago, Illinois, United States
Vanya Manthena, MPH
Research Coordinator
Pritzker School of Medicine, University of Chicago
Chicago, Illinois, United States
Lahari Vuppaladhadiam
University of Chicago
Chicago, Illinois, United States
Julie Chor
University of Chicago Medicine
Chicago, Illinois, United States
Beth Plunkett, MD, MPH
Northshore Endeavor Health
Chicago, Illinois, United States
Isa Ryan, MD (she/her/hers)
OB/GYN
NorthShore Health
Chicago, Illinois, United States
Olivert Mbah, MPH
NorthShore Health
Chicago, Illinois, United States
Jungeun Lee, BS
Endeavor Health
Evanston, Illinois, United States
Emily Barker, MD
Washington University in St Louis
St. Louis, Missouri, United States
Laura Laursen, MD, MS
Rush University
Chicago, Illinois, United States
Leanne McCloskey, MD, MPH
Northwestern Medicine
Chicago, Illinois, United States
Sloane York, BS, MPH, MS
Rush University
Chicago, Illinois, United States
Ashish Premkumar, MD, PhD (he/him/his)
Assistant Professor
Biological Sciences Division, University of Chicago
Chicago, Illinois, United States
Previable and peri-viable preterm rupture of membranes are frequently managed with medication abortion (MAB). Little is known about how ruptured membranes affect labor duration or maternal or health outcomes in MAB when compared to intact membranes.
Study Design:
This retrospective cohort study examined patients undergoing second-trimester (2T) MAB of a singleton pregnancy at 4 academic health centers from 2009-2019. Patients who received a diagnosis of preterm labor or advanced cervical exam prior to MAB were excluded. The primary exposure was rupture of membranes (ROM) or intact membranes (IM) prior to MAB. Patients with infection diagnosed at the start of induction were included. The primary outcome was duration of labor in hours. Secondary outcomes were composite morbidity (uterine rupture, blood transfusion, intensive care unit admission, or readmission) and its components, estimated blood loss (EBL) ³500 mL and clinical chorioamnionitis (CC) Bivariate analyses were performed for composite morbidity and its components due to low frequency of outcome occurrence. Multivariate analyses were performed for EBL >500ml and CC. For the primary outcome, a survival analysis, censoring at the time of delivery, was performed.
Results:
1,341 patients were included, 344 (25.7%) with ROM and 997 (74.3%) with IM. On bivariate analyses, there were significant differences in baseline characteristics between groups (Table1). ROM was associated with decreased labor duration compared to IM (HR 2.5, 95% CI 2.1-2.9); this was significant after adjusting for age, race, body mass index, parity and site of delivery (aHR 2.4, 95% CI 2.1-2.8), (Figure1). There were no significant differences in secondary outcomes, with the exception of a higher likelihood of EBL ³500 (aRR 1.54, 95% CI 1.1-2.2) and CC (aRR 1.9, 95% CI 1.3-2.7).
Conclusion:
ROM prior to 2T MAB is associated with shorter labor duration labor than IM. There was an increased likelihood of CC and higher blood loss without need for blood transfusion among people with ROM. These findings can be used in counseling patients undergoing 2T MAB.